Mediators of Inflammation / 2020 / Article / Tab 1

Research Article

Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

Table 1

Basal characteristics of patients infected with COVID-19.

NDM ()T2D () value

Age distribution
 25-49, (%)6 (19.6%)5 (13.5%)0.592
 50-64, (%)10 (30.3%)15 (40.5%)0.372
 ≥65, (%)17 (51.5%)17 (45.9%)0.641
Age (years)0.690
Sex
 Female, (%)15 (45.5%)18 (48.6%)0.699
Severity classification
 Mild type, (%)16 (48.5%)7 (18.9%)
 Moderate type, (%)13 (39.4%)20 (54.1)
 Severe cases, (%)4 (12.1%)9 (24.3%)
 Critically ill type, (%)0 (0.0%)1 (2.7%)
Comorbidities at admission
 Mixed bacterial infection, (%)4 (12.1%)12 (32.3%)
 Cardiovascular diseases, (%)14 (42.4%)21 (77.8%)0.231
 Digestive system disease, (%)2 (6.1%)3 (8.1%)0.895
 Respiratory system diseases, (%)2 (6.1%)3 (8.1%)0.895
 Chronic kidney disease, (%)2 (6.1%)5 (18.5%)0.521
 Chronic liver disease, (%)1 (3.0%)1 (2.7%)0.628
 HIV infection, (%)0 (0.0%)0 (0.0%)1.000
 Septic shock, (%)0 (0.0%)0 (0.0%)1.000

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.